Related Experiment Video

Updated: May 3, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.2K

[Diabetes mellitus and dementia]

Haruo Hanyu1

  • 1Department of Geriatric Medicine, Tokyo Medical University.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|February 14, 2014
PubMed

Insights

Diabetes mellitus may cause a unique dementia subtype, distinct from Alzheimer's or vascular dementia. This "diabetes-related dementia" is linked to specific diabetes factors, not brain lesions.

Area of Science:

  • Neurology
  • Endocrinology
  • Gerontology

Context:

  • Diabetes mellitus (DM) is a known risk factor for dementia, including vascular dementia (VaD) and Alzheimer's disease (AD).
  • Existing research often links dementia to AD pathology or cerebrovascular issues.
  • A distinct dementia subgroup associated with DM-specific factors requires characterization.

Purpose:

  • To identify and characterize a novel dementia subgroup linked to diabetes mellitus.
  • To differentiate this subgroup from AD and VaD based on clinical and imaging features.
  • To explore the underlying mechanisms, including insulin resistance, inflammation, and oxidative stress.

Summary:

  • A new dementia entity, termed "diabetes-related dementia," is described.
  • This subgroup is characterized by old age, high HbA1c, long diabetes duration, insulin use, and specific cognitive profiles (impaired attention, less word recall impairment).
  • It lacks typical AD pathology markers, parietotemporal hypoperfusion on SPECT, or MRI cerebrovascular lesions, and shows less medial temporal lobe atrophy.

Impact:

  • This characterization may lead to improved diagnostic criteria for dementia in diabetic patients.
  • Understanding diabetes-related dementia can inform targeted therapeutic strategies.
  • Identifying this distinct entity highlights the complex interplay between metabolic health and cognitive decline.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

5.9K
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

4.6K

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75